Robert Ross Carter serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Robert Ross Carter has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 17, 2025 involved receiving (via award) 195 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | TOI | $0 | Award | 195 | $N/A | Discretionary |
Robert Ross Carter currently holds 235,369 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Ross Carter has been a net neutral trader of TOI stock. They have purchased $0 and sold $0 worth of shares.
Robert Ross Carter's most recent insider trade was on Nov 17, 2025, when they sold 195 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted